Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-7624 in Healthy Adult Participants
Clinical trial NCT06920693 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06920693
- Sponsor
- Generate Biomedicines
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-27
- Primary completion
- 2026-08-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.